Lockheed Martin Investment Management Co. Purchases 8,380 Shares of Danaher Corporation $DHR

Lockheed Martin Investment Management Co. grew its position in Danaher Corporation (NYSE:DHR) by 49.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,340 shares of the conglomerate’s stock after acquiring an additional 8,380 shares during the period. Lockheed Martin Investment Management Co.’s holdings in Danaher were worth $5,024,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Ceredex Value Advisors LLC raised its position in shares of Danaher by 1.6% during the second quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock worth $49,262,000 after acquiring an additional 3,862 shares during the last quarter. Chicago Capital LLC increased its position in Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares during the period. Weitz Investment Management Inc. raised its holdings in Danaher by 6.1% during the 2nd quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock worth $104,094,000 after purchasing an additional 30,300 shares during the last quarter. Nvwm LLC lifted its position in Danaher by 20.4% during the 2nd quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock valued at $1,401,000 after purchasing an additional 1,204 shares during the period. Finally, ASR Vermogensbeheer N.V. boosted its stake in shares of Danaher by 1.9% in the 2nd quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock valued at $63,787,000 after purchasing an additional 6,136 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 0.9%

NYSE:DHR opened at $239.99 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The stock has a 50-day moving average price of $229.99 and a two-hundred day moving average price of $212.84. The stock has a market cap of $169.52 billion, a price-to-earnings ratio of 49.48, a PEG ratio of 3.68 and a beta of 0.89. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.71 EPS. As a group, equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on DHR shares. Robert W. Baird set a $247.00 price target on shares of Danaher in a research note on Wednesday, October 22nd. TD Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. HSBC raised their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Deutsche Bank Aktiengesellschaft upped their price objective on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, JPMorgan Chase & Co. raised their target price on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Twenty equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $252.09.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.